TODAY : Monday, 21 April 2025
Code
PRDA
Title
PT Prodia Widyahusada Tbk
Address
Head Office:
Address:Prodia Tower, Jl. Kramat Raya No. 150
Jakarta Pusat 10430, Indonesia
Phone:(021) 3144 182
Fax:(021) 3144 181
E-mail:investor.relation@prodia.co.id
Website:www.prodia.co.id
Background

Currently, the Company's principal activity is to provide health check up.

Business cp product

Currently, the Company's principal activity is to provide health check up.

Subsidiary affiliation
SubsidiariesDomicileBusiness%
PT Prodia OHI InternationalJakartaHealth services40
PT Prodia Stemcell IndonesiaJakartaHealth support services95
PT Prodia Diagnostic LineCikarangTrade and industry80
PT Innovasi DiagnostikaJakartaHealth services52
Commissioners
President Commissioner: Drs. Andi Widjaja, MBA
Commissioner: Drs. Gunawan Prawiro Soeharto
Commissioner: Dra. Endang Wahjuningtyas Hoyaranda
Independent Commissioner: Joseph Fellipus Peter Luhukay
Independent Commissioner: Keri Lestari Dandan
Per 30 Sep 2023
Directors
President Director: Dr. Dewi Muliaty, M.Si
Director: Liana Kuswandi, SE,M.Fin
Director: Andri Hidayat, M.Si
Director: Dr. Indriyanti Rafi Sukmawati, M.Si
Director: Ida Zuraida
Per 30 Sep 2023
Underwriter
PT. Citigroup Securities Indonesia
PT. Credit Suisse Securities Indonesia
PT Indo Premier Securities
Share registrar
PT Datindo Entrycom
Share holders
ShareholdersShares%
PT Prodia Utama53437500057
Bio Majesty Pte.Ltd.14062500015
Ida Zuraida4000
Public26249960028
As of Sep 30, 2023
History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @ Rp 650007-Dec-2016100187500000937500000

Other infos

Created date
2023-11-03 14:32:31
Revised date
2023-11-03 14:32:31
Finance
 
PT Prodia Widyahusada Tbk
 
Financial Statetment Date
Fiscal Year Ends
Months Covered in Income St
 
Summary Covered in Income St
Cash and Cash Equivalents
Receivables
Inventories
Current Assets
Fixed Assets
Other Assets
Non Current Assets
Total Assets
Current Liabilities
Longterm Liabilities
Total Liabilities
Authorized
Paid-up Capital
Par Value
Paid-up Capital Shares
Retained Earnings
Total Equity
Minority Interest
 
Summary of Income Statement
Total Sales
Cost of Good Sold
Gross Profit
Operating Profit
Other Income
Earning Before Tax
Tax
Net Income
Close Price
 
Per Share Data (Rp)
Eps (annualized)
Book Value
 
Financial Ratios
Debt Equity Ratio (X)
Roa(%)
Roe(%)
Npm(%)
Opm(%)
Gross Profit Margin (%)
Total Assets Turnover
 
Cash Flow
CF from Operation Activities
CF from Investing Activities
CF from Financing Activities
Net Increase in Cash & Cash Equivalent
Cash & Cash Equivalent at Beginning of the Year
Cash & Cash Equivalent at The End of the Year
2015-12-31
Dec
12
 
 
44,976,920.67
78,407,626.56
25,785,616.04
196,036,331.10
196,284,269.45
1,775,621.82
381,829,697.55
577,866,028.65
145,095,917.23
306,442,756.13
451,538,673.36
75.00
75,000,000.00
1,000,000.00
75.00
85,036,978.71
126,327,355.29
0.00
 
 
1,197,727,222.01
511,193,688.10
686,533,533.91
96,941,583.51
-19,951,661.28
76,989,922.23
17,964,927.81
59,024,994.42
0.00
 
 
786,999.93
1,684,364.74
 
 
3.57
10.21
46.72
4.93
8.09
57.32
2.07
 
 
158,164,814.20
63,410,959.04
-219,158,670.17
2,417,103.07
45,112,170.08
44,976,920.67